Share on StockTwits
 

Mallinckrodt PLC (NYSE:MNK) was upgraded by Zacks from a “neutral” rating to an “outperform” rating in a research note issued to investors on Thursday, AnalystRatings.NET reports. The firm currently has a $69.20 price target on the stock. Zacks‘ price target points to a potential upside of 6.40% from the stock’s previous close.

MNK has been the subject of a number of other recent research reports. Analysts at Morgan Stanley downgraded shares of Mallinckrodt PLC from an “overweight” rating to an “equal weight” rating in a research note on Wednesday. Finally, analysts at Leerink Swann raised their price target on shares of Mallinckrodt PLC to $55.00 in a research note on Friday, February 7th. Three investment analysts have rated the stock with a sell rating, three have assigned a hold rating and five have issued a buy rating to the company. The stock has a consensus rating of “Hold” and an average target price of $52.03.

In other Mallinckrodt PLC news, CEO Mark Trudeau sold 14,890 shares of the stock in a transaction dated Monday, February 3rd. The stock was sold at an average price of $56.12, for a total value of $835,626.80. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link.

Mallinckrodt PLC (NYSE:MNK) traded up 1.00% during mid-day trading on Thursday, hitting $66.89. The stock had a trading volume of 995,253 shares. Mallinckrodt PLC has a 1-year low of $41.00 and a 1-year high of $67.44. The stock’s 50-day moving average is $56.6 and its 200-day moving average is $48.56. The company has a market cap of $3.886 billion and a price-to-earnings ratio of 65.12.

Mallinckrodt PLC (NYSE:MNK) last issued its quarterly earnings data on Thursday, February 6th. The company reported $0.88 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.66 by $0.22. The company had revenue of $540.20 million for the quarter, compared to the consensus estimate of $539.24 million. The company’s revenue for the quarter was up 7.2% on a year-over-year basis. Analysts expect that Mallinckrodt PLC will post $2.77 EPS for the current fiscal year.

Mallinckrodt public limited company (NYSE:MNK) is a global specialty pharmaceuticals company.

To view Zacks’ full report, visit www.zacks.com

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.